MEDIFAST Long Term Debt To Capitalization from 2010 to 2024
| MED Stock | USD 18.30 0.14 0.77% |
Long Term Debt To Capitalization | First Reported 2010-12-31 | Previous Quarter 0.13 | Current Value 0.13 | Quarterly Volatility 0.03812076 |
Check MEDIFAST INC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEDIFAST INC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.8 M, Interest Expense of 2.6 M or Selling General Administrative of 678.4 M, as well as many indicators such as Price To Sales Ratio of 0.65, Dividend Yield of 0.1 or PTB Ratio of 4.14. MEDIFAST financial statements analysis is a perfect complement when working with MEDIFAST INC Valuation or Volatility modules.
MEDIFAST | Long Term Debt To Capitalization |
Latest MEDIFAST INC's Long Term Debt To Capitalization Growth Pattern
Below is the plot of the Long Term Debt To Capitalization of MEDIFAST INC over the last few years. It is MEDIFAST INC's Long Term Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEDIFAST INC's overall financial position and show how it may be relating to other accounts over time.
| Long Term Debt To Capitalization | 10 Years Trend |
|
Long Term Debt To Capitalization |
| Timeline |
MEDIFAST Long Term Debt To Capitalization Regression Statistics
| Arithmetic Mean | 0.07 | |
| Geometric Mean | 0.06 | |
| Coefficient Of Variation | 54.59 | |
| Mean Deviation | 0.03 | |
| Median | 0.05 | |
| Standard Deviation | 0.04 | |
| Sample Variance | 0 | |
| Range | 0.0968 | |
| R-Value | 0.55 | |
| Mean Square Error | 0 | |
| R-Squared | 0.30 | |
| Significance | 0.03 | |
| Slope | 0 | |
| Total Sum of Squares | 0.02 |
MEDIFAST Long Term Debt To Capitalization History
About MEDIFAST INC Financial Statements
MEDIFAST INC stakeholders use historical fundamental indicators, such as MEDIFAST INC's Long Term Debt To Capitalization, to determine how well the company is positioned to perform in the future. Although MEDIFAST INC investors may analyze each financial statement separately, they are all interrelated. For example, changes in MEDIFAST INC's assets and liabilities are reflected in the revenues and expenses on MEDIFAST INC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MEDIFAST INC. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Long Term Debt To Capitalization | 0.12 | 0.13 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:Check out the analysis of MEDIFAST INC Correlation against competitors. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share 0.67 | Revenue Per Share 61.769 | Quarterly Revenue Growth (0.41) | Return On Assets 0.0477 |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.